Summary: Creatine is widely recognized for supporting muscle energy, but it is also essential for healthy brain function and development. In people with creatine deficiency disorders, oral supplements often fail to correct neurological problems because the blood-brain barrier prevents sufficient creatine from reaching the brain.
Scientists are testing a promising targeted delivery technique that bypasses this barrier and transports creatine directly into brain tissue. Early laboratory results suggest this approach could restore brain energy balance and improve neurodevelopmental outcomes for conditions that currently leave many patients with permanent cognitive and developmental challenges.
Key Facts
- Creatine and the brain: Creatine supports cellular energy production in neurons and contributes to processes linked to memory, learning, and seizure control.
- Limitations of supplements: While dietary creatine often increases muscle mass and body weight for affected patients, it typically does not resolve severe neurodevelopmental impairments because it does not cross the blood-brain barrier efficiently.
- New delivery strategy: Researchers are developing focused ultrasound–guided delivery to transport creatine past the brain’s protective barrier and into targeted brain regions.
Source: Virginia Tech
Creatine is commonly viewed as a muscle supplement, but its role in brain health can be critical for survival and quality of life.
“Creatine is essential for energy-demanding cells throughout the body, including skeletal muscle, the heart, and the brain,” said Chin-Yi Chen, a research scientist at Virginia Tech’s Fralin Biomedical Research Institute at VTC.
Chen is a member of a team using focused ultrasound to open brief, controlled passages across the blood-brain barrier so creatine can enter the brain directly. This research, led by Assistant Professor Cheng-Chia “Fred” Wu, has received a $30,000 grant from the Association for Creatine Deficiencies to support early-stage experiments.
In the brain, creatine interacts with phosphate groups to support the production and recycling of adenosine triphosphate (ATP), the main energy currency of cells. Beyond energy metabolism, creatine also affects neurotransmitter systems and neuronal signaling pathways that are essential for cognitive function.
For instance, creatine influences inhibitory signaling mediated by the neurotransmitter gamma-aminobutyric acid (GABA), which helps limit neuronal excitability in the central nervous system. Through these effects, creatine can impact seizure susceptibility, learning, memory formation, and overall brain development.
Emerging studies propose that creatine may even act similarly to a neurotransmitter: it is released by glial cells and can modulate communication between neurons. When genetic creatine synthesis or transport is disrupted, as in creatine deficiency disorders, both peripheral tissues and the brain can be affected.
Patients with creatine deficiency disorders often see improvements in muscle mass and physical strength with oral creatine, but many still struggle with profound neurodevelopmental deficits that affect speech, cognition, and daily functioning. The primary obstacle is the blood-brain barrier—a selective physical and biochemical shield that prevents many circulating molecules from entering brain tissue, including therapeutically needed creatine.
Wu’s lab specializes in therapeutic focused ultrasound, a noninvasive technique that precisely concentrates sound waves to create a temporary and reversible opening in the blood-brain barrier. This controlled access enables delivery of drugs, biologics, or metabolites into specific brain regions without damaging surrounding healthy tissue.
Although Wu is also exploring focused ultrasound for pediatric brain tumors, he and collaborators recognized its potential for treating creatine transporter deficiency and other creatine-related neurodevelopmental disorders. Collaboration with clinicians at Children’s National Hospital and interactions at the Children’s National Research & Innovation Campus helped connect the basic science team with medical geneticists facing these unmet clinical needs.
The Focused Ultrasound Foundation has designated Virginia Tech and Children’s National as Centers of Excellence, enabling multidisciplinary teams—clinicians, trial designers, and laboratory researchers—to design translational studies that could support future clinical trials for targeted brain delivery of creatine.
“Finding a lab environment where we can advance from foundational research to therapies that might help patients was a turning point,” Chen said. He and the team plan initial experiments that use focused ultrasound to deliver creatine across the blood-brain barrier in animal models, with the goal of restoring normal brain mass and improving neurodevelopmental outcomes in models of creatine deficiency.
About this neuroscience research news
Author: Leigh Anne Kelley
Source: Virginia Tech
Contact: Leigh Anne Kelley – Virginia Tech
Image: The image is credited to Neuroscience News